JPRN-UMIN000038160已完成未知
Effects of pemafibrate on metabolic parameters in patients with diabetes - Effects of pemafibrate on metabolic parameters in patients with diabetes
Akishima Clinic0 个研究点目标入组 27 人开始时间: 2019年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 27
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients having hepatic and renal dysfunction (serum levels of AST, ALT, and gamma-GTP >100 U/L and/or serum creatinine level >2.0 mg/dL)
研究者
相似试验
招募中
不适用
Pemafibrate Randomized controlled study to Evaluate whether to reduce the risk of new onset of diabetes CompAred with diet therapy in patients with Under pre or early diabetic condiTION complicated with hypertriglyceridemiaDiabetesJPRN-jRCTs031190139Osamu Tomonaga20
招募中
不适用
Effect of pemafibrate on lipid and bile acid metabolism in patients with fatty liver or primary biliary cholangitisfatty liver, PBCJPRN-UMIN000039125Tokai University School of Medicine80
招募中
Unknown
Study of changes in the blood of patients of exogenous Cushing syndrome which is caused by use and misuse of steroids for a long timeCTRI/2023/09/057814Yenepoya University
进行中（未招募）
1 期
Effect of Bezafibrate on muscle metabolism during exercise in patients with fat metabolic disorders in skeletal muscle - Bezafibrate studyEvaluation of the effect of Bezafibrate on muscle metabolism during exercise in patients with VLCAD and CPT II deficiencyMedDRA version: 12.0Level: LLTClassification code 10029316Term: Neuromuscular disorder NOSEUCTR2008-006704-27-DKeuromuscular Research Unit, Copenhagen University Hospital Rigshopspitalet22
尚未招募
不适用
Clinical benefit of pemafibrate in patients with primary biliary cholangitis (PBC) with dyslipidemiaprimary biliary cholangitisJPRN-UMIN000039350Shinshu University Faculty of Medicine, Department of Gastroenterology60